Explore evidence

1.51 aORSRI patients presenting with runny nose were more likely to have SARS-CoV-2 infection compared to those who did not, with an adjusted odds ratio of 1.51.

KenyaCOVID-19observed July 2022 to October 2023published 2026VaccinePubMeddocument of 8 observations

44.5 %The average relative survival from cervical cancer in the 11 countries was 44.5% at 3 years.

Kenyacancer du col de l'utérusobserved 2005 to 2015published 2020International journal of cancereurope_pmcdocument of 6 observations

27.2 per_100_person_yearsCT/NG incidence was 27.2 per 100 person years for MSM.

KenyaCT/NG infectionpublished 2025BMJ openPubMeddocument of 4 observations

18 %In a competing risk model, viral suppression increased by 18% for each additional year of age among pregnant and postpartum women living with HIV attending a large referral facility in Kenya from 2015 to 2019.

KenyaVIH/sidaobserved 2015 to 2019published 2022AIDS and behaviorPubMeddocument of 4 observations

14 %Infection with Schistosoma mansoni was associated with a 14% higher estimated proportion of active TB cases in HIV-infected individuals.

Kenyatuberculoseobserved 2014 and 2017published 2021Journal of acquired immune deficiency syndromes (1999)PubMeddocument of 2 observations

1.51 odds_ratioPrincipal component 1 (PC1), comprising VEGF, MIP-1β, VEGF-C and IL-4, was significantly associated with HIV-1 acquisition with an adjusted odds ratio of 1.51 (95% CI: 1.14–2.00) and p=0.004.

KenyaVIH/sidapublished 2023Frontiers in immunologyPubMeddocument of 3 observations

14 mutationsOut of 17 new mutations, 14 resulted in virologic failure.

KenyaVIH/sidapublished 2021The Pan African medical journalPubMeddocument of 3 observations

23,262 patientsA total of 23262 (84.2%) of the 27641 patients eligible for early refill received an extra 3-month supply of antiretrovirals in Kisumu County, Kenya during the coronavirus disease 2019 pandemic.

KenyaVIH/sidapublished 2020AIDS (London, England)PubMeddocument of 2 observations

81 %Among 97 children with HIV on isoniazid preventive therapy, 81% were virally suppressed (<1000 copies/ml).

KenyaVIH/sidaobserved 2019 through 2020published 2024AIDS (London, England)PubMeddocument of 5 observations

41 slidesAt a local referring hospital, 41 malaria slides demonstrated both morphologic and genetic evidence of leukemia.

Kenyaleukemia · paludismepublished 2022Pediatric blood & cancerPubMeddocument of 6 observations

750 patientsAmong symptomatic adults aged 18–39 years targeted by the point-of-care NAAT intervention, one acute HIV infection (AHI) patient was identified for every 750 patients tested.

Kenyaacute HIV infectionpublished 2022HIV medicinePubMeddocument of 6 observations

37.5 %Most stage 4 participants were moderately malnourished (37.5%) and severely malnourished (29.4%).

Kenyacancer (non précisé)published 2017BMC NutritionOpenAlexdocument of 12 observationsDOI 10.1186/s40795-017-0181-z

47 %An expert algorithm for malaria had a sensitivity of 47% in assigning causes of death from verbal autopsy questionnaires.

Kenyapaludismepublished 1996Bulletin of the World Health Organizationeurope_pmcdocument of 2 observations

3 self-testsParticipants offered a median of three self-tests to sexual partners.

KenyaVIH/sidapublished 2020Journal of the International AIDS SocietyPubMeddocument of 15 observations

8.3 %Among HIV-infected patients in Central Kenya, those on TB treatment during their last known visit decreased from 8.3% in 2004 to 3.9% in 2014.

Kenyatuberculose · VIH/sidaobserved 2004 to 2014published 2021BMC infectious diseasesPubMeddocument of 10 observations

74 %Of the 230 participants encouraged to stop PrEP according to strategy recommendations, 170 (74%) did so.

KenyaVIH/sidapublished 2020BMC public healthPubMed

The most recent common ancestor of the six Comoros SARS-CoV-2 genomes was dated to 30th Oct-2020, with a 95% credibility interval from 6th Sep-2020 to 10th Dec-2020.

KenyaCOVID-19observed 30th Oct-2020published 2021Wellcome open researcheurope_pmcdocument of 3 observations

Kenya introduced a quadrivalent HPV vaccine (GARDASIL-4) for ten-year-old girls in late 2019.

Kenyainfection à HPVobserved late 2019published 2023VaccinePubMeddocument of 6 observations

44.7 %Eight months of spatial repellent use starting in September reduced malaria infections by 44.7% in western Kenya.

Kenyapaludismepublished 2026Epidemiology and infectionPubMeddocument of 4 observations

13.3 %13.3% of the participants showed signs of depression.

Kenyacancer du seinpublished 2025JCO global oncologyPubMeddocument of 5 observations

86 %86% of the adolescents and young adults living with HIV were satisfied with the disclosure process.

KenyaVIH/sidaobserved 2019published 2023Frontiers in public healthPubMeddocument of 18 observations

93 %At baseline, 56 out of 60 participants living with HIV (93%) had initiated antiretroviral therapy.

KenyaVIH/sidapublished 2023BMC health services researchPubMeddocument of 12 observations

-45 USDBetter management was associated with lower unit costs for HIV testing services (HTS) of $-45.

KenyaHIV testing services (HTS) · VIH/sidapublished 2025PloS onePubMeddocument of 8 observations

7.1 %A positive history of acute attacks of adenolymphangitis was given by 7.1% of the population in the low endemicity community.

Kenyaadenolymphangitispublished 2002The American journal of tropical medicine and hygieneeurope_pmcdocument of 12 observationsDOI 10.4269/ajtmh.2002.66.550

1,694 individualsAmong children and adolescents living with HIV in central Kenya, 1,694 (35.1%) were enrolled at WHO stage III disease.

KenyaVIH/sidapublished 2022AIDS research and human retrovirusesPubMeddocument of 18 observations